DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 210 filers reported holding DIPLOMAT PHARMACY INC in Q2 2018. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $150,000 | -44.0% | 11,174 | -18.5% | 0.01% | -33.3% |
Q3 2018 | $268,000 | -22.8% | 13,717 | +1.2% | 0.01% | -30.8% |
Q2 2018 | $347,000 | +27.1% | 13,560 | -1.0% | 0.01% | +18.2% |
Q1 2018 | $273,000 | +1.5% | 13,701 | +2.0% | 0.01% | 0.0% |
Q4 2017 | $269,000 | +7.6% | 13,430 | +11.5% | 0.01% | 0.0% |
Q3 2017 | $250,000 | +36.6% | 12,050 | -2.4% | 0.01% | +37.5% |
Q2 2017 | $183,000 | – | 12,348 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,036,670 | $42,853,000 | 1.54% |
ARMISTICE CAPITAL, LLC | 3,200,000 | $19,488,000 | 1.23% |
STEPHENS INC /AR/ | 6,600,015 | $40,194,000 | 0.91% |
S&T BANK/PA | 610,367 | $3,718,000 | 0.82% |
Rhenman & Partners Asset Management AB | 1,203,405 | $7,329,000 | 0.81% |
Matarin Capital Management, LLC | 701,445 | $4,272,000 | 0.30% |
Investors Research Corp | 89,727 | $546,000 | 0.28% |
Advisory Services Network, LLC | 598,802 | $3,647,000 | 0.22% |
FCG ADVISORS, LLC | 34,000 | $207,000 | 0.06% |
EVERENCE CAPITAL MANAGEMENT INC | 52,730 | $321,000 | 0.05% |